Companies that run trials stand to lose billions of dollars per year because of failures related to recruitment, retention, protocol deviations and corrupted data. Trials.ai is fixing the two root causes of these failures: Study Design & Execution, that result in 50% of effective treatments failing FDA approval. Our platform applies artificial intelligence to make the process of conducting clinical trials safer, faster and easier.
聽
Now the FDA is forcing change industry wide by mandating standardized study data be submitted electronically. With 50% of research still being done on paper, this creates a major shift in how these companies collect and handle data that must be synthesized and...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
